WaveMan
WaveMan · Company
HIMS · Hims & Hers Health, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

HIMS Hims & Hers Health (HIMS) Insider Trading, Ownership & Congress Trades

Healthcare Services · Services-offices & clinics of doctors of medicine · CIK 0001773751
Quote by TradingView
Form 144 · 11
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
324
13F, latest reported quarter
Conversions, 180 days
41
Codes C/M, not in net · $285.5K priced

What the filings say about HIMS

Insiders, 180 days
-$8.6M net sold
1 buyer · 7 sellers · 52% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: purchase, 2025-08-04
Planned sales (Form 144), 90 days
$3.5M
11 notices

Hims & Hers Health insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, Hims & Hers Health, Inc. insiders sold a net $8.6M of stock across 620 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.

Insider
Filed
Shares
Value
Since filing
Boughton Soleil
Chief Legal Officer
SELL
2026-10-15 SECtraded 2026-10-14
3,461
$100.6K
-1.3%
Context
  • 85 earlier Form 4 trades (code P or S) here by this insider (85 sales), the last on Sep 30, 2026.
  • The trade is 1.2% of the 297,348 shares held after it.
  • 3 other insiders sold within 30 days.
  • 324 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Legal Officer Boughton Soleil sold about $100.6K of HIMS under a 10b5-1 plan on Oct 14, 2026; 3 other insiders sold within 30 days and 324 funds added in the latest 13F quarter.
Okupe Oluyemi
Chief Financial Officer
SELL
2026-10-02 SECtraded 2026-10-01
2,000
$59.4K
-6.6%
Context
  • 95 earlier Form 4 trades (code P or S) here by this insider (1 buy, 94 sales), the last on Sep 22, 2026.
  • The trade is 0.9% of the 234,527 shares held after it.
  • 3 other insiders sold within 30 days.
  • 324 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Okupe Oluyemi sold about $59.4K of HIMS under a 10b5-1 plan on Oct 1, 2026; 3 other insiders sold within 30 days and 324 funds added in the latest 13F quarter.
Boughton Soleil
Chief Legal Officer
SELL
2026-10-02 SECtraded 2026-09-30
3,461
$101.0K
-6.6%
Context
  • 84 earlier Form 4 trades (code P or S) here by this insider (84 sales), the last on Sep 16, 2026.
  • The trade is 1.2% of the 300,809 shares held after it.
  • 3 other insiders sold within 30 days.
  • 324 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Legal Officer Boughton Soleil sold about $101.0K of HIMS under a 10b5-1 plan on Sep 30, 2026; 3 other insiders sold within 30 days and 324 funds added in the latest 13F quarter.
Okupe Oluyemi
Chief Financial Officer
SELL
2026-09-23 SECtraded 2026-09-22
29,277
$876.8K
-5.4%
Context
  • 94 earlier Form 4 trades (code P or S) here by this insider (1 buy, 93 sales), the last on Sep 17, 2026.
  • The trade is 12.4% of the 236,527 shares held after it.
  • 3 other insiders sold within 30 days.
  • 324 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Okupe Oluyemi sold about $876.8K of HIMS under a 10b5-1 plan on Sep 22, 2026; 3 other insiders sold within 30 days and 324 funds added in the latest 13F quarter.
Okupe Oluyemi
Chief Financial Officer
SELL
2026-09-18 SECtraded 2026-09-17
12,313
$354.9K
-5.6%
Context
  • 93 earlier Form 4 trades (code P or S) here by this insider (1 buy, 92 sales), the last on Aug 19, 2026.
  • The trade is 4.9% of the 251,804 shares held after it.
  • 4 other insiders sold within 30 days.
  • 324 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Financial Officer Okupe Oluyemi sold about $354.9K of HIMS under a 10b5-1 plan on Sep 17, 2026; 4 other insiders sold within 30 days and 324 funds added in the latest 13F quarter.
620 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 615 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$8.6M over 180 days
-$4.0M over 90 days
below 63% of Healthcare Services
Congress
no House purchase disclosed in the last 12 months
Funds
324 funds bought in last quarter
more than 90% of Healthcare Services
Revenue
+59.0% year over year
more than 91% of Healthcare Services
Margin
5.5% net margin
more than 71% of Healthcare Services
Buybacks
$90.0M repurchased, FY to 2025-12-31
more than 61% of Healthcare Services
Short interest
25.6% of the float short (float per yahoo 2026-10-26) · 5.3 days to cover · settled 2026-09-30
What changed in the last 30 days
Oct 15Chief Legal Officer Boughton Soleil sold $201.5K under a 10b5-1 plan (2 trades, Sep 30 to Oct 14)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 14Officer Boughton Soleil filed to sell $100.6K by Oct 14 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Oct 2Chief Financial Officer Okupe Oluyemi sold $59.4K under a 10b5-1 plan (Oct 1)
Why it matters
A 10b5-1 plan schedules trades months ahead, so this says little about what the insider thinks today.
Oct 1Officer Okupe Oluyemi filed to sell $59.4K by Oct 1 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.
Sep 30Officer Boughton Soleil filed to sell $101.0K by Sep 30 (Form 144)
Why it matters
A Form 144 is a notice of intent to sell; the sale may not happen, and it says nothing about the price.

Watch HIMS

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-41.6%12M
-69%-45%-21%+3%2025-102025-122026-022026-042026-062026-082026-10 2026-03-17 · Chi Michael sold $2.4M2026-06-18 · Okupe Oluyemi sold $1.9M2026-05-26 · WELLS DAVID B bought $1.2M2026-04-16 · Okupe Oluyemi sold $956.3K2026-06-17 · Elshenawy Mohamed sold $946.3K2026-09-22 · Okupe Oluyemi sold $876.8K2025-11-17 · Okupe Oluyemi sold $853.5K2026-06-18 · Carroll Patrick Harrison sold $830.4K2025-12-22 · Okupe Oluyemi sold $824.8K2026-08-19 · Boughton Soleil sold $691.8K2026-06-22 · Okupe Oluyemi sold $619.2K2026-04-20 · Okupe Oluyemi sold $588.6K2025-12-17 · Chi Michael sold $504.8K2026-04-17 · Okupe Oluyemi sold $501.1K2026-08-18 · Autor Deborah M. sold $467.1K2026-06-17 · Chi Michael sold $441.9K2026-09-15 · Chi Michael sold $398.2K2025-12-17 · Carroll Patrick Harrison sold $367.9K2026-09-17 · Okupe Oluyemi sold $354.9K2025-12-17 · Becklund Irene sold $308.8K2026-01-05 · Okupe Oluyemi sold $306.5K2026-04-20 · Boughton Soleil sold $283.9K2026-01-20 · Okupe Oluyemi sold $275.1K2026-08-17 · Okupe Oluyemi sold $261.8K2026-07-06 · Okupe Oluyemi sold $261.4K2025-12-17 · Autor Deborah M. sold $259.0K2026-07-17 · Okupe Oluyemi sold $229.2K2026-06-16 · Becklund Irene sold $229.1K2026-09-15 · Elshenawy Mohamed sold $225.8K2026-03-20 · Okupe Oluyemi sold $219.1K2026-05-18 · Okupe Oluyemi sold $187.9K2026-09-16 · Boughton Soleil sold $173.7K2026-08-19 · Okupe Oluyemi sold $148.1K2026-06-17 · Becklund Irene sold $141.4K2026-02-03 · Okupe Oluyemi sold $139.1K2026-03-17 · Becklund Irene sold $136.5K2025-10-27 · Boughton Soleil sold $132.1K2026-03-17 · Boughton Soleil sold $118.8K2025-11-10 · Boughton Soleil sold $112.2K2026-09-30 · Boughton Soleil sold $101.0K2026-10-14 · Boughton Soleil sold $100.6K2026-09-02 · Boughton Soleil sold $98.0K2026-10-14 · Boughton Soleil filed to sell $100.6K2026-10-01 · Okupe Oluyemi filed to sell $59.4K2026-09-30 · Boughton Soleil filed to sell $101.0K2026-09-22 · Okupe Oluyemi filed to sell $876.8K2026-09-17 · Okupe Oluyemi filed to sell $354.9K2026-09-16 · Boughton Soleil filed to sell $173.7K2026-09-15 · Chi Michael filed to sell $398.2K2026-09-15 · Elshenawy Mohamed filed to sell $225.8K2026-09-02 · Boughton Soleil filed to sell $98.0K2026-08-19 · Boughton Soleil filed to sell $691.8K2026-08-18 · Autor Deborah M. filed to sell $467.1K2026-07-22 · Pendarvis Christiane filed to sell $113.3K2026-07-06 · Oluyemi Okupe filed to sell $1.1M2026-06-18 · Carroll Patrick Harrison filed to sell $830.4K
Insider buyInsider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns HIMS: institutional holders (13F)

13F holdings, latest reported quarter
BlackRock, Inc.
28,703,514 sh
$995.2M
VANGUARD PORTFOLIO MANAGEMENT LLC
10,559,314 sh
$366.1M
VANGUARD CAPITAL MANAGEMENT LLC
9,541,384 sh
$330.8M
STATE STREET CORP
8,145,699 sh
$282.4M
MORGAN STANLEY
7,152,498 sh
$248.0M

Congress trades in HIMS

STOCK Act disclosures, US House only, filed up to 45 days after the trade
Lisa McClain
Bought 2025-08-04 · disclosed 39 days later
$1,001 - $15,000
All stocks members of Congress are buying · Every member's trades

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

HIMS planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
Boughton Soleil
Filed 2026-10-14
$100.6K
Okupe Oluyemi
Filed 2026-10-01
$59.4K
Boughton Soleil
Filed 2026-09-30
$101.0K
Okupe Oluyemi
Filed 2026-09-22
$876.8K
Okupe Oluyemi
Filed 2026-09-17
$354.9K

HIMS mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
REX IncomeMax Option Strategy ETF
$1.8M position · as of 2026-06-30
4.7%
Global X HealthTech ETF
$975.7K position · as of 2026-05-31
3.9%
Amplify Online Retail ETF
$3.3M position · as of 2026-06-30
3.0%
Kurv High Income ETF
$1.2M position · as of 2026-05-31
2.9%
State Street(R) SPDR(R) S&P(R) Health Care Services ETF
$2.8M position · as of 2026-06-30
2.0%
Invesco Dorsey Wright Healthcare Momentum ETF
$3.7M position · as of 2026-07-31
1.6%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Executive pay vs shareholder return · Andrew Dudum
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$23.0M
$159.7M
$17.5M
+110%
+13%
2024
$24.6M
$110.3M
$7.2M
+57%
-2%
2023
$14.4M
$21.4M
$6.5M
-42%
-24%
2022
$10.8M
$10.7M
$5.0M
-58%
-53%
2021
$15.2M
$26.8M
$3.3M
-58%
-10%
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $8.6M sold by insiders over 180 days, 324 funds added last quarter, $3.5M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
NTRACSTLPGNYWGSPRVATDOCAVAHGHADUSSERABDSXBLLN

HIMS financials

Revenue growth
+59.0%
XBRL, annual
Net margin
5.5%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$2.6B
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
-5.5%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
$61.5M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Debt to equity
4.21x
long-term 2026-06-30 plus current 2020-12-31 (66 months older than the period end); equity 2026-06-30
Cash flow to debt
0.19x
TTM operating cash flow over long-term 2026-06-30 plus current 2020-12-31 (66 months older than the period end)
Return on equity
-32.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
-5.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on capital employed
-8.2%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Enterprise value
n/a
no share count filed
FCF yield
n/a
no share count filed
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$2.3B$1.5B$872.0M$526.9M
Gross profit$1.7B$1.2B$714.9M$408.7M
Operating income$105.6M$61.9M-$29.5M-$68.7M
Net income$128.4M$126.0M-$23.5M-$65.7M
EPS (diluted)0.510.53-0.11-0.32
Operating cash flow$300.0M$251.1M$73.5M-$26.5M
Cash$228.6M$220.6M$96.7M$46.8M
Long-term debt$972.6M$0n/an/a
Buybacks$90.0M$83.0M$2.0M$0
SEC XBRL, fiscal years, as known on 2026-10-27

HIMS Stock Sonar score 6/7 axes

Find similar shapesCompare

HIMS ranks highest on growth (91st percentile) and institutional and government (89th), and lowest on risk and compliance (7th), among Healthcare Services peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
37
Inputs
  • Return on equity-32.0% · 30 pct, sector of 70
  • Return on assets-5.2% · 45 pct, sector of 88
  • Return on invested capitalpre-tax loss, no effective tax rate to apply
  • Return on capital employed-8.2% · 34 pct, sector of 68
Financial health
26
Inputs
  • Debt to equity4.21x · 5 pct, sector of 61
  • Cash flow to debt0.19x · 48 pct, sector of 66
Growth
91
Inputs
  • Revenue growth, YoY+59.0% · 91 pct, sector of 87
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
52
Inputs
  • Net Form 4 buying (codes P and S), 180d-$4.9M · 40 pct, sector of 64
  • Insider buyers, 180d1 · 63 pct, sector of 64
Institutional and government
89
Inputs
  • Funds adding, latest quarter324 · 90 pct, sector of 73
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quarters$2.9M · 88 pct, universe of 1,063
Risk and compliance
7
Inputs
  • Short interest, % of float+25.6% · 3 pct, sector of 95
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+20.8% · 11 pct, sector of 72
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

HIMS filings, in plain words

Are Hims & Hers Health insiders buying or selling HIMS?

In the 180 days to 2026-10-27, Hims & Hers Health insiders were net sellers, a net $8.6M: $1.2M of purchases and $9.8M of sales reported on Form 4, by 1 buyer and 7 sellers.

Have members of Congress traded HIMS?

Yes, but not in the year to 2026-10-27; the latest on record is a purchase by Lisa McClain dated 2025-08-04.

Are there planned insider sales of HIMS?

Yes. 11 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $3.5M of stock; the latest, by Boughton Soleil, was filed 2026-10-14.

Read the full summary

In the 180 days to 2026-10-27, Hims & Hers Health insiders were net sellers of HIMS, a net $8.6M across purchases and sales reported on Form 4 by 1 buyer and 7 sellers. 52% of the 23 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Members of Congress have disclosed trades in HIMS, none in the last year; the latest on record is a purchase by Lisa McClain dated 2025-08-04. Insiders filed 11 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $3.5M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies